Get answers to your specific medical questions from UM Medical Center experts.
Immune hemolytic anemia is a disorder characterized by anemia due to premature destruction of red blood cells by the immune system.
Immune hemolytic anemia occurs when antibodies form against the body's own red blood cells. The antibodies will destroy the blood cells because these blood cells are recognized as foreign material within the body. The antibodies may be acquired by blood transfusion, pregnancy (if the baby's blood type is different from the mother's), as a complication of another disease, or from a reaction to medications.
If the cause of antibody formation is disease or medication, it is referred to as secondary immune hemolytic anemia. The cause may also be unknown, as in idiopathic autoimmune hemolytic anemia , which accounts for one-half of all immune hemolytic anemias . The disease may start quite rapidly and be very serious, or it may remain mild and not require specific treatment. Risk factors are related to the causes.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |